Elinor Meiby

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Fragment-based drug discovery (FBDD) has become a new strategy for drug discovery where lead compounds are evolved from small molecules. These fragments form low affinity interactions (dissociation constant (K(D)) = mM - μM) with protein targets, which require fragment screening methods of sufficient sensitivity. Weak affinity chromatography (WAC) is a(More)
  • 1